http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
문현종,황성욱 대한흉부외과학회 2010 Journal of Chest Surgery (J Chest Surg) Vol.43 No.6
Background: Spontaneous hemopneumothorax is characterized by the accumulation of air and more than 400 mL of blood in pleural cavity without any apparent cause. It is a rare disease and can cause life-threatening situation. We analyzed clinical reviews of two medical centers to aid in optimal management. Material and Method:Retrospective review between March 2003 and August 2010 with 18 spontaneous hemopneumothorax patients was made. Result: These 18 patients were comprised of 15 male and 3 female with average 24.6 years (range 15∼46 years). Almost patients (16) underwent a closed thoracostomy initially and 15 patients received video-assisted thoracic surgery (VATS). Mean postoperative chest tube removal was 2.9 days and one complication was post-removal pneumothorax. During the follow-up periods there were no other complications and recurrence. Conclusion:Proper initial diagnosis and management of spontaneous hemopneumothorax prevent significant hypovolemic shock. Video-assisted thoracic surgery should be considered an early surgical management in spontaneous hemopneumothorax. However conservative manage without bleb excision may be effective in selected patients. 배경: 자연성 혈기흉은 외상이나 다른 뚜렷한 원인 없이 흉강 내 공기와 400 mL 이상의 혈액이 동시에 쌓이는 질환이다. 드문 질환이지만 생명을 위협할 수도 있는 질환이기도 하다. 이 질환의 적절한치료를 알아보고자 두 병원에서 치료받은 환자들을 분석하였다. 대상 및 방법: 2003년 3월부터 2010년 8월까지 치료받은 18명의 자연성 혈기흉 환자들을 후향적으로 조사하였다. 결과: 18명의 환자들중 남자 15명 여자 3명이었고 평균 나이는 24.6세이었다. 16명의 환자는 우선적으로 폐쇄식 흉관 삽입술을 시행하였으며 15명의 환자는 흉강경을 통한 수술적 치료를 하였다. 수술 후 흉관 제거는 평균2.9일에 이루어졌으며, 수술 후 합병증으로 흉관 제거 후 기흉이 한 명 있었다. 퇴원 후 다른 합병증이나 재발은 추적기간 동안 없었다. 결론: 초기의 적절한 진단과 치료가 치명적인 쇼크 상태를 방지하며, 흉강경을 통한 조기 수술이 자연성 혈기흉의 치료가 될 것이다. 그러나 보전적 치료도 일부 환자에게는 효과적이다.
베체씨 병에서의 동종 이식편을 이용한 대동맥 근위부 치환술 - 1례 보고 -
문현종,안혁,Moon, Hyeon-Jong,Ahn, Hyuk 대한흉부심장혈관외과학회 1997 Journal of Chest Surgery (J Chest Surg) Vol.30 No.1
구강 생식기의 궤양, 안구와 피부 병변을 특징으로 하는 베체씨 병의 예후는 중추 신경계, 위장관, 혈 관계의 합병증에 의존된다. 심장의 병변 특히 대동맥 판막 폐쇄부전증은 매우 드물고, 일반적으로 혈역 학적 불안정성은 개심술을 통하여 치료된다. 그러나 많은 환자에서 인공 판막의 이탈, 판막 주변 누출. 전도 장애, 가성 동맥류 등의 심각한 합병증이 보고되어 왔다. 이런 합병증을 막기 위하여 많은 노력이 있었으며 그중 하나는 동종 이식편읜 사용이었다. 서울대학교병원 흉부외과에서는 베체씨 대동맥염으로 인해 인조 판막 이탈이 있었던 39세 남자 환자에서 동종 이식편을 이용한 대동맥 근위부 치환술을 시도하여 좋은 결과를 얻었기에 문헌 고찰과 함께 보고하는 바이다. The prognosis of Behfet's disease characterized by recurrent orogenltal ulcers and ocular and skin lesions depends upon the complications in the central nervous system, the gastrointestinal tract And the vascular system. Cardiac involvement, especially aortic regurgitation, is quite uncommon and hemodynamic instability is usually treated with ope heart surgery. But serious postoperative complications had been reported in many cases, which are prosthetic valve detachment, paravalvular leakage, conduction disturbance, and false aneurysm. Many efforts to prevent the complications have been made such as application of cryopreseved homograft. We have described an experience of root replacement with homograft in d 39 year-old male patient for prosthetic valve detachment because of Behfet's aorlitis with a review of the literatures regarding treatment, complication, and prognosis.
The Efficacy of the Prophylactic Use of Octreotide after a Pancreaticoduodenectomy
문현종,허진석,최성호,조재원,최동욱,김용일 연세대학교의과대학 2005 Yonsei medical journal Vol.46 No.6
This study was performed to analyze the efficacy of the prophylactic use of octreotide (Novartis, Stein, Switzerland) for pancreatic fistula following a pancreaticoduodenectomy. The medical records of 190 patients who underwent a pancreaticoduodenectomy at the Samsung Medical Center in Seoul, Korea between January 2000 and December 2002 were reviewed. Patients were divided into either the octreotide (n= 81) or control group (n=109). The octreotide group received subcutaneous injections of 100μg of octreotide every 12 hours for more than five days after surgery. The control group was not treated with octreotide. The criterion of pancreatic fistula was the drainage of the amylase rich fluid, over 500U/mL in the three days after surgery. The morbidity and mortality rates were 32.1% and 1.2% in the octreotide group and 31.2% and 0% in the control group, respectively. Pancreatic fistula was the second most common complication (8.4%). In the univariate analysis, octreotide was ineffective in reducing pancreatic fistula (p=0.26). However, in the multivariate regression analysis, combined gastrectomy (p=0.018), cellular origin of the disease (p=0.049), and use of octreotide (p=0.044) were the risk factors that increased the frequency of pancreatic fistula. Therefore, the routine use of octreotide after a pancreaticoduodenectomy should be avoided until a worldwide consensus is established.